WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Overview
Canada - TSX:WELL-DB - CA94947LAC69
100.5 CAD
+0.05 (+0.05%)
Taking everything into account, WELL-DB scores 3 out of 10 in our fundamental rating. WELL-DB was compared to 15 industry peers in the Health Care Providers & Services industry. WELL-DB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WELL-DB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
WELL-DB had negative earnings in the past year.
WELL-DB had a positive operating cash flow in the past year.
In multiple years WELL-DB reported negative net income over the last 5 years.
Of the past 5 years WELL-DB 4 years had a positive operating cash flow.
1.2 Ratios
WELL-DB's Return On Assets of -6.37% is on the low side compared to the rest of the industry. WELL-DB is outperformed by 66.67% of its industry peers.
The Return On Equity of WELL-DB (-15.57%) is worse than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of WELL-DB (39.21%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of WELL-DB has grown nicely.
The Profit Margin and Operating Margin are not available for WELL-DB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL-DB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WELL-DB has been increased compared to 5 years ago.
The debt/assets ratio for WELL-DB has been reduced compared to a year ago.
2.2 Solvency
WELL-DB has an Altman-Z score of 13.30. This indicates that WELL-DB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of WELL-DB (13.30) is better than 100.00% of its industry peers.
WELL-DB has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL-DB is somewhat dependend on debt financing.
WELL-DB has a Debt to Equity ratio of 0.68. This is in the better half of the industry: WELL-DB outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.3 |
ROIC/WACCN/A
WACC8.4%
2.3 Liquidity
A Current Ratio of 0.93 indicates that WELL-DB may have some problems paying its short term obligations.
WELL-DB has a better Current ratio (0.93) than 66.67% of its industry peers.
A Quick Ratio of 0.92 indicates that WELL-DB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.92, WELL-DB is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL-DB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -221.43%.
The Revenue has grown by 20.36% in the past year. This is a very strong growth!
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
3.2 Future
Based on estimates for the next years, WELL-DB will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.87% on average per year.
WELL-DB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.34% yearly.
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL-DB. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 331.75, WELL-DB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL-DB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, WELL-DB is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 331.75 |
4.2 Price Multiples
66.67% of the companies in the same industry are cheaper than WELL-DB, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 383.96 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WELL-DB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as WELL-DB's earnings are expected to grow with 34.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.11%
EPS Next 3Y34.36%
5. Dividend
5.1 Amount
WELL-DB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL-DB (10/27/2025, 7:00:00 PM)
100.5
+0.05 (+0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap25.52B
Revenue(TTM)1.10B
Net Income(TTM)-128618000
Analysts81
Price Target171.45 (70.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)6.8%
EPS NQ rev (1m)-5.09%
EPS NQ rev (3m)19.65%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 331.75 | ||
| P/S | 23.29 | ||
| P/FCF | N/A | ||
| P/OCF | 5506.25 | ||
| P/B | 30.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 383.96 |
EPS(TTM)-0.51
EYN/A
EPS(NY)0.3
Fwd EY0.3%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.02%
SpS4.32
BVpS3.25
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.34 | ||
| Cap/Depr | 25.5% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 6.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 13.3 |
F-Score2
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y42.51%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES / WELL-DB.CA FAQ
What does WELL-DB do?
WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. The company is headquartered in Vancouver, British Columbia and currently employs 3,200 full-time employees. The company went IPO on 2012-12-17. Its healthcare and digital platform includes front and back-office management software applications that help physicians. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. The Canadian Patient Services segment provides primary care and allied health clinic operations in Canada and specialty care and accredited diagnostic health services from WDC. The WELL Health USA Patient and Provider Services segment includes U.S. primary care telehealth operations from Circle Medical; U.S. primary care operations from WISP; specialized care gastroenterology anesthesia services, and specialized medical recruitment and staffing services. The SaaS and Technology Services segment includes aggregation of electronic medical records, billing and revenue cycle management solutions, digital applications, and cybersecurity operating segments.
What is the current price of WELL-DB stock?
The current stock price of WELL-DB.CA is 100.5 CAD. The price increased by 0.05% in the last trading session.
How is the ChartMill rating for WELL HEALTH TECHNOLOGIES?
WELL-DB.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock traded?
WELL-DB.CA stock is listed on the Toronto Stock Exchange exchange.